Facebook
Instagram
Linkedin
Pinterest
Reddit
Twitter
Youtube
Sign in
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk (Dairy) Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons & Offers
Resources
Newsletter
SnackSafely Manufacturer Partnership
Take 2 Epinephrine Reminder Flyers
Put Your School on the Map
About Us
SnackSafely Media Kit
SnackSafely Advertising Guide
Terms and Conditions
Privacy Policy
Contact Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Terms and Conditions
Password recovery
Recover your password
your email
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk (Dairy) Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons & Offers
Resources
Newsletter
SnackSafely Manufacturer Partnership
Take 2 Epinephrine Reminder Flyers
Put Your School on the Map
About Us
SnackSafely Media Kit
SnackSafely Advertising Guide
Terms and Conditions
Privacy Policy
Contact Us
Search
Home
Emerging Therapy
Page 19
Emerging Therapy
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Aquestive Works with FDA to Resolve Hurdles for its New Sublingual Epinephrine Candidate
Dave Bloom
-
2026/01/09
Hope on the Horizon: Ten Food Allergy Research Breakthroughs in 2025
Very Low-Dose Multi-Nut OIT Promising for Children with Multiple Food Allergies
DBV to Submit FDA Application After Viaskin Peanut Patch Achieves Goals in Phase 3 Trial
Mabylon Begins Human Clinical Trials of New Peanut Allergy Treatment
Oral Immunotherapy: What You Should Know, and What’s New (Webinar)
Dave Bloom
-
2020/04/30
0
Pending Litigation Shows Food Allergy Treatments in Development are Sometimes Overhyped
Dave Bloom
-
2020/04/24
0
BlueWillow Completes Preclinical Studies of Intranasal Peanut Allergy Vaccine
Dave Bloom
-
2020/04/03
0
FDA Has Questions About Viaskin Peanut Efficacy, Delays Meeting with DBV...
Dave Bloom
-
2020/03/17
0
ARS to Present Data from Intranasal Epinephrine (ARS-1) Studies at AAAAI...
News Wire ~ 3rd Party Press Release
-
2020/03/02
0
FDA Advisory Committee Meeting to Review Viaskin Peanut for the Treatment...
News Wire ~ 3rd Party Press Release
-
2020/02/22
0
Alladapt Immunotherapeutics Secures $60 Million in Series C Financing for Development...
News Wire ~ 3rd Party Press Release
-
2020/02/21
0
End Allergies Together Announces Winners of $1 Million Grand Challenge to...
News Wire ~ 3rd Party Press Release
-
2020/02/12
0
FDA Opens Door for Clinical Development of Aquestive Therapeutics Anaphylaxis Treatment
News Wire ~ 3rd Party Press Release
-
2020/02/06
0
Aimmune Licenses Exclusive Worldwide Rights to Xencor’s XmAb®7195 for the Development...
News Wire ~ 3rd Party Press Release
-
2020/02/05
0
1
...
18
19
20
...
31
Page 19 of 31